Comprehensive genomic profiling of advanced Merkel cell carcinoma to reveal insights into immunotherapy response.

Todd C. Knepper,Jeffery S. Russell,Meagan Montesion,Ethan Sokol,Garrett M. Frampton,Phil Stephens,Lee A. Albacker,Michael J. Schell,James A. DeCaprio,Kenneth Y. Tsai,Andrew S. Brohl

Comprehensive genomic profiling of advanced Merkel cell carcinoma to reveal insights into immunotherapy response.

2018

Todd C. Knepper
Jeffery S. Russell
Meagan Montesion
Ethan Sokol
Garrett M. Frampton
Phil Stephens
Lee A. Albacker
Michael J. Schell
James A. DeCaprio
Kenneth Y. Tsai
Andrew S. Brohl

9523Background: Merkel Cell Carcinoma (MCC) is a rare and aggressive neuroendocrine skin malignancy. Recently, high response rates to immune checkpoint inhibitor therapy (ICT) have been demonstrate...

Keywords:

Cancer research
Merkel cell carcinoma
Pathology
Immunotherapy
Medicine
genomic profiling
Malignancy
immune checkpoint inhibitors

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations